Covid-19 and cancer patients: Choosing wisely is the key
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in Digestive and Liver Disease
- Vol. 52 (6) , 595-596
Abstract
No abstract availableFunding Information
- Ministero della Salute
This publication has 6 references indexed in Scilit:
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Digestive and Liver Disease, 2020
- Managing COVID-19 in the oncology clinic and avoiding the distraction effectAnnals of Oncology, 2020
- Implications of COVID-19 for patients with pre-existing digestive diseasesThe Lancet Gastroenterology & Hepatology, 2020
- Risk of COVID-19 for patients with cancerThe Lancet Oncology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020